Scotia Capital Inc. Novo Nordisk A S Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

A detailed history of Scotia Capital Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Scotia Capital Inc. holds 279,958 shares of NVO stock, worth $30.2 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

279,958

Previous 248,496 12.66%

Holding current value

$30.2 Million

Previous $35.5 Million 6.02%

% of portfolio

0.19%

Previous 0.21%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $3.75 Million - $4.58 Million	31,462 Added 12.66%	279,958 $33.3 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $3.16 Million - $3.79 Million	25,768 Added 11.57%	248,496 $35.5 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $1.76 Million - $2.34 Million	17,204 Added 8.37%	222,728 $28.6 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $6.3 Million - $7.56 Million	71,720 Added 53.6%	205,524 $21.3 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $5.86 Million - $12.9 Million	64,485 Added 93.03%	133,804 $12.2 Million
Q2 2023 Aug 03, 2023	SELL	$155.98 - $172.65 $16,845 - $18,646	-108 Reduced 0.16%	69,319 $11.2 Million
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $1,323 - $1,591	-10 Reduced 0.01%	69,427 $11 Million
Q4 2022 Feb 09, 2023	SELL	$102.55 - $135.33 $229,506 - $302,868	-2,238 Reduced 3.12%	69,437 $9.4 Million
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $33,824 - $41,510	-355 Reduced 0.49%	71,675 $7.14 Million
Q2 2022 Aug 05, 2022	SELL	$103.24 - $121.81 $513,206 - $605,517	-4,971 Reduced 6.46%	72,030 $8.03 Million
Q1 2022 May 09, 2022	SELL	$93.1 - $112.54 $395,488 - $478,069	-4,248 Reduced 5.23%	77,001 $8.55 Million
Q4 2021 Feb 11, 2022	BUY	$95.88 - $117.08 $37,297 - $45,544	389 Added 0.48%	81,249 $9.1 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $337,004 - $425,627	3,992 Added 5.19%	80,860 $7.76 Million
Q2 2021 Aug 12, 2021	BUY	$67.66 - $84.76 $424,160 - $531,360	6,269 Added 8.88%	76,868 $6.44 Million
Q1 2021 May 06, 2021	SELL	$67.06 - $75.82 $43,857 - $49,586	-654 Reduced 0.92%	70,599 $4.76 Million
Q4 2020 Feb 11, 2021	SELL	$63.89 - $73.8 $102,032 - $117,858	-1,597 Reduced 2.19%	71,253 $4.98 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $15,858 - $17,484	-249 Reduced 0.34%	72,850 $5.06 Million
Q2 2020 Aug 11, 2020	SELL	$58.54 - $67.94 $115,440 - $133,977	-1,972 Reduced 2.63%	73,099 $4.81 Million
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $44,761 - $58,625	905 Added 1.22%	75,071 $4.52 Million
Q4 2019 Feb 13, 2020	SELL	$49.86 - $58.26 $73,643 - $86,050	-1,477 Reduced 1.95%	74,166 $4.3 Million
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $188,686 - $212,063	-3,969 Reduced 4.99%	75,643 $3.91 Million
Q2 2019 Aug 13, 2019	SELL	$46.79 - $52.47 $861,029 - $965,552	-18,402 Reduced 18.77%	79,612 $4.07 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $1.53 Million - $1.73 Million	-32,907 Reduced 25.14%	98,014 $5.13 Million
Q4 2018 Feb 11, 2019	SELL	$41.54 - $47.25 $1.21 Million - $1.37 Million	-29,099 Reduced 18.18%	130,921 $6.03 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $833,637 - $913,506	-17,828 Reduced 10.02%	160,020 $7.54 Million
Q2 2018 Aug 13, 2018	SELL	$44.29 - $50.42 $28,478 - $32,420	-643 Reduced 0.36%	177,848 $8.69 Million
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $173,788 - $208,373	-3,584 Reduced 1.97%	178,491 $8.79 Million
Q4 2017 Feb 13, 2018	SELL	$47.53 - $53.73 $427,294 - $483,032	-8,990 Reduced 4.71%	182,075 $9.77 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $995,212 - $1.19 Million	24,185 Added 14.49%	191,065 $9.2 Million
Q2 2017 Aug 15, 2017	BUY	N/A	166,880	166,880 $7.16 Million

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Novo Nordisk A S Transaction History